Method for reducing serum uric acid levels
AssigneeAffiliated Medical Research, Inc.
InventorShreekrishna M. Gadekar
Life of this patent
Estimating the term…
Abstract
Novel pharmaceutical compositions containing as the active ingredient the compound 5-methyl-1-phenyl-2-(1H)-pyridone are described. Such compositions have been found to have a metabolic property which causes significant lowering of serum uric acid levels in humans and other mammals. The compositions containing 5-methyl-1-phenyl-2-(1H)-pyridone caused no irritation on oral administration or when applied to specific target tissues showed no significant irritation or other sequelae.
Claims6
A method for reducing the uric acid level in the serum of a mammal in need of such reduction which comprises administering to said mammal a therapeutically effective amount of 5-methyl-1-phenyl-2-(1H)-pyridone.
Dependencies are inferred from the claim text.